In an era of rapid disruption, static data is no longer enough. We bridge the gap between complex market data and actionable strategy through our unique RaaS (Research-as-a-Service) framework. Explore our latest Industry Intelligence Briefings, methodology deep-dives, and expert analysis designed to provide the clarity you need for high-stakes board presentations, acquisition due diligence, and long-term strategic planning. Need specific answers? Commission a bespoke intelligence study tailored to your requirements.
Real, verified FY2026 rankings of India's top pharma companies by both revenue and manufacturing/export scale -- two genuinely different lis…
ADCs are growing at 18% CAGR inside an oncology market averaging 11% overall — and Keytruda's patent cliff hits just as that wave reaches fu…
Perlite and vermiculite market estimates vary by 4x across published reports because no public company anchors the sizing. We cross-checked …
Global GLP-1 manufacturing capacity is racing from $45 billion to a projected $180 billion by 2031. The real capacity bottleneck - and the r…
Drug Product Formulation and Fill-Finish, not API peptide synthesis, is the single largest stage of the GLP-1 manufacturing value chain — an…
Oral semaglutide is already commercial. A five-company pipeline of dual-agonist and biosimilar challengers is advancing behind it. Inside th…
Eli Lilly's market cap crossed $1 trillion in August 2026 - the first healthcare company ever to do so. Inside the $1.65T global pharmaceuti…
With the market's underlying forecast pointing toward $2.45 trillion by 2031, and every one of the top 10 companies now navigating some comb…
Why a single tablet might involve chemistry in China, formulation in India, and consumption in the United States — and why market sizing the…
The single largest driver of pharmaceutical market growth today is the GLP-1 receptor agonist and broader cardiometabolic therapy revolution…
This briefing applies BCG's growth-share framework — Stars, Cash Cows, Question Marks, and Dogs — directly to the disclosed segment economic…
How verification research replaced a proposed key player with a company few fleet managers have heard of, revealing the real structural faul…
